
Bennett M. Celsa
Supervisory Patent Examiner (ID: 14197, Phone: (571)272-0807 , Office: P/1600 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1600, 1621, 1627, 3991, 1654, 1811, 1618, 1639 |
| Total Applications | 690 |
| Issued Applications | 420 |
| Pending Applications | 112 |
| Abandoned Applications | 158 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1575431
[patent_doc_number] => 06469065
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Nitrosated and nitrosylated -adrenergic receptor antagonist, compositions and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/387724
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 35789
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469065.pdf
[firstpage_image] =>[orig_patent_app_number] => 09387724
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/387724 | Nitrosated and nitrosylated -adrenergic receptor antagonist, compositions and methods of use | Aug 31, 1999 | Issued |
Array
(
[id] => 4157530
[patent_doc_number] => 06156732
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Azole peptidomimetics as thrombin receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/387489
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6787
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156732.pdf
[firstpage_image] =>[orig_patent_app_number] => 387489
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/387489 | Azole peptidomimetics as thrombin receptor antagonists | Aug 31, 1999 | Issued |
Array
(
[id] => 4288026
[patent_doc_number] => 06268339
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Lanthionine bridged peptides'
[patent_app_type] => 1
[patent_app_number] => 9/384061
[patent_app_country] => US
[patent_app_date] => 1999-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16018
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268339.pdf
[firstpage_image] =>[orig_patent_app_number] => 384061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/384061 | Lanthionine bridged peptides | Aug 25, 1999 | Issued |
Array
(
[id] => 1475680
[patent_doc_number] => 06388081
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => '4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries'
[patent_app_type] => B1
[patent_app_number] => 09/376670
[patent_app_country] => US
[patent_app_date] => 1999-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26626
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 857
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/388/06388081.pdf
[firstpage_image] =>[orig_patent_app_number] => 09376670
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/376670 | 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries | Aug 15, 1999 | Issued |
Array
(
[id] => 6882626
[patent_doc_number] => 20010049098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-06
[patent_title] => 'METHOD FOR PRODUCING STRUCTURED, SELF-ORGANIZED MOLECULAR MONOLAYERS OF INDIVIDUAL MOLECULAR SPECIES, IN PARTICULAR SUBSTANCE LIBRARIES.'
[patent_app_type] => new
[patent_app_number] => 09/355443
[patent_app_country] => US
[patent_app_date] => 1999-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2734
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20010049098.pdf
[firstpage_image] =>[orig_patent_app_number] => 09355443
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/355443 | Method for producing structured, self-organized molecular monolayers of individual molecular species, in particular substance libraries | Jul 27, 1999 | Issued |
Array
(
[id] => 4189931
[patent_doc_number] => 06153585
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Arylsulfonanilide derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/353976
[patent_app_country] => US
[patent_app_date] => 1999-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12158
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 433
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153585.pdf
[firstpage_image] =>[orig_patent_app_number] => 353976
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/353976 | Arylsulfonanilide derivatives | Jul 14, 1999 | Issued |
Array
(
[id] => 1213541
[patent_doc_number] => 06710168
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-23
[patent_title] => 'Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same'
[patent_app_type] => B1
[patent_app_number] => 09/353368
[patent_app_country] => US
[patent_app_date] => 1999-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 39500
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/710/06710168.pdf
[firstpage_image] =>[orig_patent_app_number] => 09353368
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/353368 | Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same | Jul 13, 1999 | Issued |
Array
(
[id] => 1037654
[patent_doc_number] => 06872803
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-29
[patent_title] => 'Peptides'
[patent_app_type] => utility
[patent_app_number] => 09/349707
[patent_app_country] => US
[patent_app_date] => 1999-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14444
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872803.pdf
[firstpage_image] =>[orig_patent_app_number] => 09349707
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/349707 | Peptides | Jul 7, 1999 | Issued |
Array
(
[id] => 1312711
[patent_doc_number] => 06610649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-26
[patent_title] => 'Insulin C-peptides'
[patent_app_type] => B2
[patent_app_number] => 09/269439
[patent_app_country] => US
[patent_app_date] => 1999-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7211
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610649.pdf
[firstpage_image] =>[orig_patent_app_number] => 09269439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269439 | Insulin C-peptides | Jul 7, 1999 | Issued |
Array
(
[id] => 931068
[patent_doc_number] => 06979572
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-12-27
[patent_title] => 'Compositions and methods for inhibiting inward-rectifier potassium channels'
[patent_app_type] => utility
[patent_app_number] => 09/743054
[patent_app_country] => US
[patent_app_date] => 1999-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6230
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/979/06979572.pdf
[firstpage_image] =>[orig_patent_app_number] => 09743054
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/743054 | Compositions and methods for inhibiting inward-rectifier potassium channels | Jul 6, 1999 | Issued |
Array
(
[id] => 6890624
[patent_doc_number] => 20010007855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-12
[patent_title] => 'SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES'
[patent_app_type] => new-utility
[patent_app_number] => 09/284906
[patent_app_country] => US
[patent_app_date] => 1999-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 5003
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20010007855.pdf
[firstpage_image] =>[orig_patent_app_number] => 09284906
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/284906 | SEMI-SYNTHETIC STUDIES TOWARD DIDEMNIN ANALOGUES | Jul 1, 1999 | Abandoned |
Array
(
[id] => 7636495
[patent_doc_number] => 06380162
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Ice inhibiting peptides'
[patent_app_type] => B1
[patent_app_number] => 09/297369
[patent_app_country] => US
[patent_app_date] => 1999-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3953
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/380/06380162.pdf
[firstpage_image] =>[orig_patent_app_number] => 09297369
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/297369 | Ice inhibiting peptides | Jun 30, 1999 | Issued |
Array
(
[id] => 1598784
[patent_doc_number] => 06475486
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates'
[patent_app_type] => B1
[patent_app_number] => 09/343698
[patent_app_country] => US
[patent_app_date] => 1999-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 13582
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475486.pdf
[firstpage_image] =>[orig_patent_app_number] => 09343698
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/343698 | Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates | Jun 29, 1999 | Issued |
Array
(
[id] => 7636501
[patent_doc_number] => 06380156
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Total synthesis of the amino hip analogue of didemnin A'
[patent_app_type] => B1
[patent_app_number] => 09/284905
[patent_app_country] => US
[patent_app_date] => 1999-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10166
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/380/06380156.pdf
[firstpage_image] =>[orig_patent_app_number] => 09284905
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/284905 | Total synthesis of the amino hip analogue of didemnin A | Jun 27, 1999 | Issued |
| 09/339682 | Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides | Jun 23, 1999 | Abandoned |
Array
(
[id] => 4411993
[patent_doc_number] => 06228988
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Synthesis of hydroxamic acid derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/328493
[patent_app_country] => US
[patent_app_date] => 1999-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10413
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228988.pdf
[firstpage_image] =>[orig_patent_app_number] => 328493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/328493 | Synthesis of hydroxamic acid derivatives | Jun 8, 1999 | Issued |
Array
(
[id] => 4188602
[patent_doc_number] => 06093798
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Synthesis of hydroxamic acid derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/328492
[patent_app_country] => US
[patent_app_date] => 1999-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10478
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 358
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093798.pdf
[firstpage_image] =>[orig_patent_app_number] => 328492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/328492 | Synthesis of hydroxamic acid derivatives | Jun 8, 1999 | Issued |
Array
(
[id] => 1152895
[patent_doc_number] => 06767887
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-27
[patent_title] => 'Exendin analogues, processes for their preparation and medicaments containing them'
[patent_app_type] => B1
[patent_app_number] => 09/147345
[patent_app_country] => US
[patent_app_date] => 1999-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18685
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/767/06767887.pdf
[firstpage_image] =>[orig_patent_app_number] => 09147345
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/147345 | Exendin analogues, processes for their preparation and medicaments containing them | Jun 3, 1999 | Issued |
Array
(
[id] => 1199950
[patent_doc_number] => 06723517
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-20
[patent_title] => 'Use of self-assembled monolayers to probe the structure of a target molecule'
[patent_app_type] => B1
[patent_app_number] => 09/324258
[patent_app_country] => US
[patent_app_date] => 1999-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16644
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723517.pdf
[firstpage_image] =>[orig_patent_app_number] => 09324258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/324258 | Use of self-assembled monolayers to probe the structure of a target molecule | Jun 1, 1999 | Issued |
Array
(
[id] => 1420063
[patent_doc_number] => 06506724
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-14
[patent_title] => 'Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus'
[patent_app_type] => B1
[patent_app_number] => 09/323867
[patent_app_country] => US
[patent_app_date] => 1999-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 47013
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506724.pdf
[firstpage_image] =>[orig_patent_app_number] => 09323867
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/323867 | Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus | May 31, 1999 | Issued |